Finance

Lists
Z1TS34:BVMF
Zoetis Inc Bdr
22,57 R$
0,00%
(0,00) 1D
30 սեպ, 16:51:19 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for Z1TS34...
Mkt. cap
28,75 մլրդ
Avg. vol.
3,11 հզր
Volume
0,00
52-wk high
49,23 R$
52-wk low
22,57 R$
Shares outstanding
413,22 մլն
No. of employees
14 հզր
Mkt. cap
28,75 մլրդ
Avg. vol.
3,11 հզր
Volume
0,00
52-wk high
49,23 R$
52-wk low
22,57 R$
Shares outstanding
413,22 մլն
No. of employees
14 հզր
News stories
From web sources and news partners
Investing.com
Investing.com
·
5 րոպե առաջ
Zoetis stock hits 52-week low at $69.48
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries. In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc Bdr
CEOKristin C. Peck
Employees14,5 հզր
Founded1952
HeadquartersParsippany-Troy Hills, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Websitezoetis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,40 մլրդ
2,39 մլրդ
2,26 մլրդ
2,47 մլրդ
Cost of goods sold
682,00 մլն
711,00 մլն
640,00 մլն
670,00 մլն
Cost of revenue
682,00 մլն
711,00 մլն
640,00 մլն
670,00 մլն
Research and development expenses
170,00 մլն
199,00 մլն
180,00 մլն
173,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
572,00 մլն
618,00 մլն
584,00 մլն
589,00 մլն
Operating expense
774,00 մլն
848,00 մլն
795,00 մլն
793,00 մլն
Total operating expenses
1,46 մլրդ
1,56 մլրդ
1,44 մլրդ
1,46 մլրդ
Operating income
944,00 մլն
828,00 մլն
827,00 մլն
1,00 մլրդ
Other non operating income
-
-6,00 մլն
-1,00 մլն
-2,00 մլն
EBT including unusual items
887,00 մլն
761,00 մլն
758,00 մլն
866,00 մլն
EBT excluding unusual items
899,00 մլն
780,00 մլն
779,00 մլն
948,00 մլն
Income tax expense
166,00 մլն
158,00 մլն
157,00 մլն
175,00 մլն
Effective tax rate
18,71%
20,76%
20,71%
20,21%
Other operating expenses
-
-
-
-
Net income
721,00 մլն
603,00 մլն
601,00 մլն
691,00 մլն
Net profit margin
30,04%
25,26%
26,57%
28,00%
Earnings per share
1,70
1,48
1,53
1,87
Interest and investment income
26,00 մլն
25,00 մլն
21,00 մլն
16,00 մլն
Interest expense
-58,00 մլն
-57,00 մլն
-62,00 մլն
-61,00 մլն
Net interest expenses
-32,00 մլն
-32,00 մլն
-41,00 մլն
-45,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,07 մլրդ
903,00 մլն
946,00 մլն
1,12 մլրդ
Gain or loss from assets sale
-
-
-6,00 մլն
-1,00 մլն
AI content may include mistakes. Learn more
Google Apps